Key facts
- This page summarizes UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's Form 4 filing for Aileron Therapeutics, Inc. (RNTX).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 17 Jun 2024, 19:03.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Additional SEC filing notes
Section 16 status
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents.